Toremifene versus tamoxifen for advanced breast cancer Stable (no update expected for reasons given in 'What's new')
Toremifene versus tamoxifen for advanced breast cancer Stable (no update expected for reasons given in 'What's new') is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Toremifene Versus Tamoxifen for Advanced Breast Cancer Stable (no Update Expected for Reasons Given in 'What's New')." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432961/all/Toremifene_versus_tamoxifen_for_advanced_breast_cancer_Stable__no_update_expected_for_reasons_given_in_'What's_new'_. Accessed 31 January 2023.
Toremifene versus tamoxifen for advanced breast cancer Stable (no update expected for reasons given in 'What's new'). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432961/all/Toremifene_versus_tamoxifen_for_advanced_breast_cancer_Stable__no_update_expected_for_reasons_given_in_'What's_new'_. Accessed January 31, 2023.
Toremifene versus tamoxifen for advanced breast cancer Stable (no update expected for reasons given in 'What's new'). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432961/all/Toremifene_versus_tamoxifen_for_advanced_breast_cancer_Stable__no_update_expected_for_reasons_given_in_'What's_new'_
Toremifene Versus Tamoxifen for Advanced Breast Cancer Stable (no Update Expected for Reasons Given in 'What's New') [Internet]. In: Cochrane Abstracts. [cited 2023 January 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432961/all/Toremifene_versus_tamoxifen_for_advanced_breast_cancer_Stable__no_update_expected_for_reasons_given_in_'What's_new'_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Toremifene versus tamoxifen for advanced breast cancer Stable (no update expected for reasons given in 'What's new')
ID - 432961
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432961/all/Toremifene_versus_tamoxifen_for_advanced_breast_cancer_Stable__no_update_expected_for_reasons_given_in_'What's_new'_
DB - Evidence Central
DP - Unbound Medicine
ER -